Patents matching “antibody”

US 11306155

Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibody

REGENERON PHARMACEUTICALS, INC. · Granted Apr 19, 2022 · Expires Apr 14, 2042

US 11299549

Humanized BCMA antibody and BCMA-CAR-T cells

Caribou Biosciences, Inc. · Granted Apr 12, 2022 · Expires Apr 7, 2042

US 11292835

Low dose antibody-based methods for treating hematologic malignancies

Actinium Phamaceuticals, Inc. · Granted Apr 5, 2022 · Expires Mar 31, 2042

US 11285210

Buffer formulations for enhanced antibody stability

Outlook Therapeutics, Inc. · Granted Mar 29, 2022 · Expires Mar 24, 2042

US 11286305

Complex comprising anti-transferrin receptor antibody covalently linked to an oligonucleotide that targets DUX4 RNA

Dyne Therapeutics, Inc. · Granted Mar 29, 2022 · Expires Mar 24, 2042

US 11278619

DNA antibody constructs and method of using same

Inovio Pharmaceuticals, Inc. · Granted Mar 22, 2022 · Expires Mar 17, 2042

US 11254746

Anti-PD-1 monoclonal antibody, and preparation method therefor and application thereof

SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD. · Granted Feb 22, 2022 · Expires Feb 17, 2042

US 11248039

Immunoglobulin single variable domain antibody against RSV prefusion F protein

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 15, 2022 · Expires Feb 10, 2042

US 11236173

CD38 antibody

BLACK BELT THERAPEUTICS LIMITED · Granted Feb 1, 2022 · Expires Jan 27, 2042

US 11230592

DNA antibody constructs for use against middle east respiratory syndrome coronavirus

Inovio Pharmaceuticals, Inc. · Granted Jan 25, 2022 · Expires Jan 20, 2042

US 11213592

Antibody-sting agonist conjugates and their use in immunotherapy

The Board of Regents of the University of Texas System · Granted Jan 4, 2022 · Expires Dec 30, 2041

US 11208470

DNA antibody constructs and method of using same

Inovio Pharmaceuticals, Inc. · Granted Dec 28, 2021 · Expires Dec 23, 2041

US 11197928

Sustained production of high affinity antigen specific antibody by high dose BAFF receptor-targeting mAb-siRNA conjugate

The Board of Regents of the University of Texas System · Granted Dec 14, 2021 · Expires Dec 9, 2041

US 11186626

Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loop

INTEGRATED BIOTHERAPEUTICS, INC. · Granted Nov 30, 2021 · Expires Nov 25, 2041

US 11160872

Pyrrolobenzodiazepine-antibody conjugates

ADC THERAPEUTICS SA · Granted Nov 2, 2021 · Expires Oct 28, 2041

US 11141479

Stable anti-OSMR antibody formulation

Kiniksa Pharmaceuticals, GmbH · Granted Oct 12, 2021 · Expires Oct 7, 2041

US 11135280

Modified ebolavirus glycoproteins comprising mutations in the head and base domains that increase antibody cross-reactivity

INTEGRATED BIOTHERAPEUTICS, INC. · Granted Oct 5, 2021 · Expires Sep 30, 2041

US 11135307

Peptide-containing linkers for antibody-drug conjugates

Mersana Therapeutics, Inc. · Granted Oct 5, 2021 · Expires Sep 30, 2041

US 11111309

Method of reducing expression of DUX4 in a muscle cell by administering an anti-transferrin receptor antibody linked to an oligonucleotide targeting DUX4

Dyne Therapeutics, Inc. · Granted Sep 7, 2021 · Expires Sep 2, 2041

US 11110178

Antibody adjuvant conjugates

Bolt Biotherapeutics, Inc. · Granted Sep 7, 2021 · Expires Sep 2, 2041

US 11104737

ACVR2A-specific antibody and method of treatment of muscle atrophy

Rigel Pharmaceuticals, Inc. · Granted Aug 31, 2021 · Expires Aug 26, 2041

US 11084869

Antibody-mediated neutralization of Marburg virus

The Board of Regents of the University of Texas System · Granted Aug 10, 2021 · Expires Aug 5, 2041

US 11065340

Polyoxazoline antibody drug conjugates

Serina Therapeutics, Inc. · Granted Jul 20, 2021 · Expires Jul 15, 2041

US 11058770

Ultrastable antibody ionic liquids

United States of America as represented by the Secretary of the Air Force · Granted Jul 13, 2021 · Expires Jul 8, 2041